AK
Annette C. Kuesel

Publications (9)

Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study
Article scientifique · 2025
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: Results of an open-label pharmacokinetic and safety study in an onchocerciasis endemic area in Ghana
Article scientifique · 2025
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
Article scientifique · 2024
O. volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: Results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia
Article scientifique · 2023
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
Article scientifique · 2022
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity
Article scientifique · 2017
Response to the Letter to the Editor by Eberhard et al.
Article scientifique · 2017
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings
Article scientifique · 2016
Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial
Article scientifique · 2016

Domaines principaux

Sciences de la santé9

Statistiques

Consultations17
Téléchargements0